Understanding Wegovy vs Mounjaro Dose Differences & UK Pricing
Wegovy Dose vs Mounjaro Dose: Key Mechanism Differences
When comparing Wegovy dose schedules against Mounjaro dosing protocols, the fundamental difference lies in their active ingredients and receptor targets. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This means each medication follows a different dose escalation pattern designed to optimise tolerability and effectiveness. Wegovy's dosing schedule spans 20 weeks with five distinct doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg maintenance), whereas Mounjaro follows its own tirzepatide-specific protocol.
Both medications require clinical assessment as prescription-only medicines, but understanding the Wegovy dose vs Mounjaro dose comparison helps patients and prescribers make informed decisions. The dose escalation for Wegovy is mandatory — you cannot skip doses as this increases the risk of gastrointestinal side effects. Mounjaro's dosing follows similar principles but with different target doses and timelines. At EverydayMeds, our clinical team can guide you through either dosing schedule, ensuring you understand the commitment required for each treatment option.
Complete UK Pricing: Wegovy Dose vs Mounjaro Dose Costs
Understanding the cost implications when comparing Wegovy dose vs Mounjaro dose options is crucial for treatment planning. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and reaching the 2.4mg maintenance dose at £209.99 per pen. Our discount codes FIRST40 (new customers) and DOSE25 (returning customers) are applied at checkout to achieve these listed prices. We also offer convenient bundle options like the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Ultimate Stability Trio (three 2.4mg pens) for £649.99, providing Reliable Supply continuity.
When evaluating Wegovy dose vs Mounjaro dose from a financial perspective, consider the total treatment journey cost rather than individual pen prices. Wegovy's 20-week escalation to maintenance means you'll progress through all five doses before reaching your ongoing 2.4mg weekly injections. Both treatments are available through our streamlined process: complete the 3-minute clinical assessment, await prescriber review (standard 3 working days or express 24 hours), then receive next-day cold-chain delivery once approved. Our GPhC #9012878 registered pharmacy ensures authentic medications with proper temperature-controlled logistics throughout the UK.
Clinical Evidence: Wegovy Dose vs Mounjaro Dose Effectiveness
The clinical evidence supporting each treatment comes from separate trial programmes, making direct Wegovy dose vs Mounjaro dose comparisons complex due to different study designs and populations. In Wegovy's STEP clinical trials, patients taking the full 2.4mg dose alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with sustained results of 15.2% at 2 years in STEP 5 (Wilding et al., NEJM, 2021). The STEP 2 trial demonstrated approximately clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 showed approximately clinically studied weight loss when combined with intensive behavioural therapy.
Mounjaro's clinical programme follows its own protocol with tirzepatide doses, showing efficacy across its dose range in separate studies. However, when comparing Wegovy dose vs Mounjaro dose outcomes, it's important to note that trial designs, patient populations, and endpoints differed between programmes. Both medications have demonstrated cardiovascular benefits in their respective studies — Wegovy's SELECT trial showed a 20% reduction in major cardiovascular events. Your prescriber can help interpret which evidence base aligns better with your individual health profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding how Wegovy works helps clarify why the specific dose escalation matters when considering Wegovy dose vs Mounjaro dose options. Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a natural hormone released by your intestines after eating. This hormone signals your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The gradual dose escalation from 0.25mg to 2.4mg allows your body to adapt to increasing levels of GLP-1 receptor stimulation, minimising gastrointestinal side effects whilst building therapeutic effectiveness. Each weekly injection using the pre-filled FlexTouch pen delivers consistent medication levels, working alongside your reduced-calorie diet and increased physical activity to support sustainable weight management.
EverydayMeds Ordering Process: Getting Started
Ordering either treatment through our Wegovy dose vs Mounjaro dose comparison service starts with our comprehensive 3-minute online clinical assessment. This assessment covers your medical history, current medications, weight management goals, and any contraindications to ensure safe prescribing. Our qualified prescribers review every application within 3 working days (or 24 hours with express service), considering which dosing protocol — Wegovy's semaglutide schedule or Mounjaro's tirzepatide regimen — best suits your individual circumstances. Once approved, we dispatch your medication via next-day delivery using specialised cold-chain logistics to maintain the 2-8°C temperature requirements. All orders are packaged discretely with clear injection instructions and dose escalation guidance to support your treatment journey.
Storage Advantages: Wegovy Dose vs Mounjaro Dose Practicality
Storage requirements present a practical consideration when evaluating Wegovy dose vs Mounjaro dose options for your lifestyle. Wegovy offers superior travel flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy particularly suitable for frequent travellers or those with variable schedules. Both medications must be stored in the fridge at 2-8°C before first use, but Wegovy's extended room temperature stability provides additional peace of mind. The FlexTouch pen design used for Wegovy doses features a clear dose counter and simple injection mechanism, whilst Mounjaro uses its own pen device with different handling characteristics. Our pharmacy team provides detailed storage guidance with every order to ensure medication integrity throughout your treatment.
Dose Escalation Schedules: Wegovy vs Mounjaro Timeline Comparison
The structured approach to dose increases represents a crucial difference when comparing Wegovy dose vs Mounjaro dose protocols. Wegovy follows a mandatory 20-week escalation: 4 weeks at 0.25mg, followed by 4 weeks each at 0.5mg, 1mg, and 1.7mg, before reaching the 2.4mg maintenance dose at week 17. This graduated approach allows your digestive system to adapt gradually, significantly reducing the likelihood of nausea, vomiting, or other gastrointestinal side effects that can occur with rapid dose increases. Missing doses or attempting to accelerate the schedule can compromise both safety and effectiveness.
Mounjaro's tirzepatide dosing follows its own evidence-based escalation schedule, with different target doses and timing intervals. When evaluating Wegovy dose vs Mounjaro dose timelines, consider your personal tolerance for gradual increases versus alternative schedules. Both protocols are designed based on extensive clinical research to optimise the balance between therapeutic benefit and tolerability. Your prescriber will monitor your progress through either schedule, making adjustments if needed based on your individual response and any side effects experienced.
Maximising Value: Discount Codes and Bundle Options
Smart purchasing strategies can significantly impact your Wegovy dose vs Mounjaro dose treatment costs over time. Our discount codes — FIRST40 for new customers and DOSE25 for returning patients — are applied at checkout to provide the competitive pricing listed throughout our range. For Wegovy, consider our Getting Started bundles like the Progress Duo (0.5mg & 1mg) at £189.99, which covers weeks 5-12 of your escalation with Stock Available availability. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, eliminating the need for monthly reorders once you reach your target dose. These bundle options offer convenience and supply security rather than just cost savings, ensuring treatment continuity during periods of high demand or supply fluctuations.
When planning your Wegovy dose vs Mounjaro dose budget, factor in the full escalation journey plus ongoing maintenance costs. Both treatments represent long-term commitments — clinical evidence shows patients regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting the importance of sustained use. Our pharmacy team at GPhC #9012878 can help calculate your total treatment costs and recommend the most efficient purchasing approach based on your prescribed dosing schedule and individual financial considerations.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
